ESR1 and breast carcinoma: In the present study, we investigated the contribution of Lysine deacetylases (KDAC) in the catalytic activity of NAT1 using two different breast cancer cell lines: MDA-MB-231 (ER-, PR-, HER2-) and ZR-75-1 (ER+, PR+, HER2+).